Spectral Diagnostics Inc., has announced that Dr. Paul Walker, the Company's President and Chief Executive Officer, will present at BioFinance 2012 on Wednesday, May 30, at 9:20 a.m. Eastern Time.
The conference will be held at the St. Andrew's Club & Conference Centre in Toronto, Ontario.
Dr. Walker will provide a corporate update, including information about the Company's pivotal sepsis program.
BioFinance is a prominent Canadian investor conference for the life sciences industry.
The two-day event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector.
Presenting companies span a range of industries including biologics, medical devices, drug delivery, vaccines, and diagnostics.